Thermo Fisher Scientific | TMO - Ordinary Share Capital


Thermo Fisher Scientific reported $371.62M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 2.94M Mar/2026
Agilent USD 282.22M 478K Mar/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Bio Techne USD 156.45M 703K Mar/2026
Bio-Rad Laboratories USD 26.74M 91K Jun/2026
Boston Scientific USD 1.48B 2.66M Dec/2025
Bruker USD 152.22M 282K Mar/2026
Charles River Laboratories USD 47.73M 439K Jun/2026
Danaher USD 702.9M 4.8M Jun/2026
Dentsply International USD 200.3M 700K Mar/2026
Edwards Lifesciences USD 577M 3.7M Mar/2026
General Electric Aerospace USD 1.04B 5.77M Jun/2026
Henry Schein USD 111.92M 2.51M Jun/2026
Illumina USD 151.3M 607K Jun/2026
Intuitive Surgical USD 354.16M 1.01M Jun/2026
IQVIA Holdings USD 164.6M 2.3M Jun/2026
Laboratory Of America USD 80.9M 1.4M Jun/2026
Medtronic USD 1.28B 1.38M Dec/2025
Mettler Toledo International USD 20.21M 40.9K Jun/2026
Myriad Genetics USD 93.5M 400K Dec/2025
Olympus JPY 1.1B 35.42K Mar/2026
OraSure Technologies USD 70.39M 1.87M Dec/2025
Quest Diagnostics USD 110M 1000K Jun/2026
Repligen USD 56.43M 28K Jun/2026
Revvity USD 111.63M 174K Jun/2026
Stryker USD 383.4M 416K Jun/2026
Thermo Fisher Scientific USD 371.62M 1000 Jun/2026
Veracyte USD 79.79M 1000 Jun/2026
Waters USD 98.19M 20K Jun/2026
Zimmer Biomet Holdings USD 193.4M 2.1M Jun/2026